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A series of novel flavonols were synthesized by cyclizing cor-
responding hydoxy chalcones using Algar flynn Oyamada
reaction [1]. The synthesized compounds were characterized
by various spectrochemical methods including IR,MASS, NMR
spectroscopy. Out of 13 compounds screened for antibacterial
activity [2], compoundVMF 12 (a bromo derivative) showed ac-
tivitywith an IC50 value at 0.16 μMagainst S. aureus.Compounds
VMF 1 and VMF 2 (dichloro derivatives) showed activity with
IC50 at 0.34 and 0.46 μM respectively against E. coli. Compound
VMF8 (adichloroderivative of phenyl substituted γ-benzopyrone)
exhibitedmaximum activity with an IC50 value at 0.02 μM con-
centration against P. aeruginosa. None of the compounds were
active against B. subtilis.
The anti-cancer potency of the test compoundswere evalu-
ated by MTT [3] assay for 13 test compounds on two different
cell line such as HeLa and V79 cell lines. Compounds such as
VMF7(dichloroderivative) andVMF8(dichloroderivative) showed
IC50 at 0.38 μM each, compound VMF 4 (a dichloro derivative)
showed IC50 at 0.43 μMagainst standardCisplatin andCurcumin,
showing an IC50 of 0.01 and 0.12 μM respectively against HeLa
cell lines.
The cytotoxic activity for the test compounds were also per-
formed against V79 cell lines using MTT assay method. Out of
the 13 compounds screened, compoundsVMF 4 (a dichloro de-
rivative), VMF 9 (a dichloro derivative), VMF 10 (a di bromo
derivative), and VMF 13 (a di bromo derivative) showed mod-
erate toxicity with an IC50 greater than 1 μM, whereas, other
test compounds showed IC50 greater than 2 μM against stan-
dard Cisplatin and Curcumin with their IC50 value at 0.15 and
0.19 μM respectively against V79 cell lines.
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Fig. 1 – (A) IR spectra of compound VMF 9, and (B) NMR spectra of compound VMF 3.
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